HER2 Support Group Forums - View Single Post - MUST READ-- metastatic her2+ breast cancer not necessarily the death sentence it was

Rolepaul · 07-11-2012, 06:32 AM

Ongoing research will continue. With an estimate one in nine women getting breast cancer, and one of those having HER+ cancer, the population is high enough to warrant companies to address this disease. If the population gets too small, it is harder to justify the investigational cost for an organization. If a treatment can be determined that is broad spectrum enough, ie pnencillin based treatment of infections, then the cost and ability to treat should continue to come down. This will make doctors and insurance companies be more willing to provide effective treatment. I will say that we have had exceptionally little pushback on anything, but our contribution has put a damper on what we can do as a couple.

The state of care for Herceptin positive patients can be looked at as we have gone from a slide rule to a hand held calculator. We need to move to I-phone 5s and Samsung Galaxy III in treatment. Be the research team for your personal health care. Your patient population is one.

Thank you Lani for your continued good work.

07-11-2012, 06:32 AM	#16
Rolepaul Senior Member Join Date: Jan 2012 Location: Boulder Colorado as of January 2013 Posts: 391	Re: MUST READ-- metastatic her2+ breast cancer not necessarily the death sentence it Ongoing research will continue. With an estimate one in nine women getting breast cancer, and one of those having HER+ cancer, the population is high enough to warrant companies to address this disease. If the population gets too small, it is harder to justify the investigational cost for an organization. If a treatment can be determined that is broad spectrum enough, ie pnencillin based treatment of infections, then the cost and ability to treat should continue to come down. This will make doctors and insurance companies be more willing to provide effective treatment. I will say that we have had exceptionally little pushback on anything, but our contribution has put a damper on what we can do as a couple. The state of care for Herceptin positive patients can be looked at as we have gone from a slide rule to a hand held calculator. We need to move to I-phone 5s and Samsung Galaxy III in treatment. Be the research team for your personal health care. Your patient population is one. Thank you Lani for your continued good work.